The global apheresis market was valued at $2.4 billion in 2021 and is projected to reach $5.3 billion by 2031, growing at a CAGR of 8.3% from 2022 to 2031.
WARREN, NJ, USA I6, 2024 I PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the global Phase 2 placebo-controlled CardinALS study did not meet its primary endpoint of slowing disease ...